All In MedTech

Device Trial Radar · NCT07944872

Assessment of a Tourniquet-free Surgical Reconstruction of the ACL Using the STRYKER Arthroscopy System With Regard to the Occurrence of Arthrogenic Muscle Inhibition (AMI) - an Exploratory Study

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Nov 1, 2026

Primary completion

Apr 30, 2028

Study completion Apr 30, 2028

Sponsor

Lead sponsor
Almaviva SanteAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 18, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

An ACL rupture and reconstruction may be responsible for a neurophysiological dysfunction commonly known as 'arthrogenic muscle inhibition' (AMI). AMI is responsible for the quadriceps deficits observed following an ACL rupture and thus appears to be a major limiting factor in the patient's rehabilitation and functional recovery. ACL reconstruction is performed under general or regional anaesthesia. A tourniquet may be applied to the thigh to prevent bleeding, but new arthroscopy systems, such as the STRYKER arthroscopy system, allow the surgeon to work within the joint without a tourniquet. This makes it possible to avoid the potential complications associated with the tourniquet, the compression from which can slow down the crural nerve and the sciatic nerve and affect the thigh muscles - in particular the quadriceps, which is involved in AMI - as well as the mobility of the lower limb. This study is based on the hypothesis that patients undergoing ACL reconstruction without a tourniquet using the STRYKER arthroscopy system experience less quadriceps muscle damage. Little data is available on this approach in France. This is why this study has been initiated.

Conditions

  • Cruciate Ligament Reconstruction

Interventions

  • STRYKER arthroscopy systemDevice

    This intervention differs from others which usually use tourniquet for ACL reconstruction.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. arthrogenic muscular inhibition (AMI)Time frame: One month

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Clinique des Lilas

    Les Lilas, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.